Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Mi

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Medical Cases|July 12, 2024
Metastatic Bladder Urothelial Carcinoma Masquerading as MyositisChristopher Dilli, William Mi, Miguel A Guzman
Journal of the American Society of Cytopathology|July 11, 2025
Managing TBSRTC III thyroid nodules: evaluating repeat FNA, molecular testing, and surgeryChristopher Dilli, William Mi, Daniel L Miller
Human Pathology|December 24, 2025
B72.3 serves as a new diagnostic marker for testicular Leydig cell tumorJianping Zhao, William Mi, Varsha Nair, et al.
Human Pathology|August 8, 2025
Mixed-grade papillary urothelial carcinoma with a minor high-grade component shows a significantly worse clinical outcome than low-grade papillary urothelial carcinomaWilliam Mi, Chenxuan Zang, Jianping Zhao, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Medical Cases|July 12, 2024
Metastatic Bladder Urothelial Carcinoma Masquerading as MyositisChristopher Dilli, William Mi, Miguel A Guzman
Journal of the American Society of Cytopathology|July 11, 2025
Managing TBSRTC III thyroid nodules: evaluating repeat FNA, molecular testing, and surgeryChristopher Dilli, William Mi, Daniel L Miller
Human Pathology|December 24, 2025
B72.3 serves as a new diagnostic marker for testicular Leydig cell tumorJianping Zhao, William Mi, Varsha Nair, et al.
Human Pathology|August 8, 2025
Mixed-grade papillary urothelial carcinoma with a minor high-grade component shows a significantly worse clinical outcome than low-grade papillary urothelial carcinomaWilliam Mi, Chenxuan Zang, Jianping Zhao, et al.
Pageof 1